We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$311M
AUM Growth
-$3.46M
Cap. Flow
+$5.64M
Cap. Flow %
1.82%
Top 10 Hldgs %
68.43%
Holding
57
New
10
Increased
22
Reduced
13
Closed
1

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.62M
2
URGN icon
UroGen Pharma
URGN
+$661K
3
NVDA icon
NVIDIA
NVDA
+$622K
4
ADBE icon
Adobe
ADBE
+$569K
5
AMZN icon
Amazon
AMZN
+$447K

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Consumer Discretionary 29.76%
3 Healthcare 22.18%
4 Communication Services 12.19%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$335B
$2.7M 0.87%
8,857
+792
+10% +$218K
NEE icon
27
NextEra Energy
NEE
$185B
$2.51M 0.81%
33,231
+4,005
+14% +$313K
EXEL icon
28
Exelixis
EXEL
$14B
$1.87M 0.6%
82,730
-2,815
-3% -$63.6K
LLY icon
29
Eli Lilly
LLY
$1.07T
$1.51M 0.49%
8,087
+737
+10% +$144K
ABT icon
30
Abbott
ABT
$182B
$1.08M 0.35%
9,036
NSC icon
31
Norfolk Southern
NSC
$77.1B
$1M 0.32%
3,725
-400
-10% -$101K
BA icon
32
Boeing
BA
$167B
$987K 0.32%
3,874
+150
+4% +$33.3K
BMY icon
33
Bristol-Myers Squibb
BMY
$128B
$870K 0.28%
13,779
+851
+7% +$52.9K
JNJ icon
34
Johnson & Johnson
JNJ
$641B
$819K 0.26%
4,986
COST icon
35
Costco
COST
$422B
$655K 0.21%
1,858
+285
+18% +$99.2K
JPM icon
36
JPMorgan Chase
JPM
$947B
$651K 0.21%
4,279
+460
+12% +$66.2K
URGN icon
37
UroGen Pharma
URGN
$2.02B
$606K 0.2%
+31,131
New +$661K
DE icon
38
Deere & Co
DE
$169B
$543K 0.17%
1,450
MRK icon
39
Merck
MRK
$323B
$486K 0.16%
6,604
PFE icon
40
Pfizer
PFE
$141B
$476K 0.15%
13,147
PAYX icon
41
Paychex
PAYX
$41.1B
$470K 0.15%
4,800
TROW icon
42
T. Rowe Price
TROW
$25.5B
$432K 0.14%
2,515
TGT icon
43
Target
TGT
$63.7B
$424K 0.14%
2,140
+350
+20% +$65.5K
CAT icon
44
Caterpillar
CAT
$402B
$393K 0.13%
1,697
T icon
45
AT&T
T
$167B
$358K 0.12%
15,660
-257
-2% -$5.68K
NUE icon
46
Nucor
NUE
$56.4B
$351K 0.11%
4,375
CLVS
47
DELISTED
Clovis Oncology, Inc.
CLVS
$351K 0.11%
+50,000
New +$335K
EOLS icon
48
Evolus
EOLS
$407M
$325K 0.1%
+25,000
New +$230K
DUK icon
49
Duke Energy
DUK
$100B
$253K 0.08%
2,626
IDXX icon
50
Idexx Laboratories
IDXX
$43.9B
$250K 0.08%
+510
New +$256K

Similar funds

Bender Robert & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Bender Robert & Associates held 57 positions worth $311M, down 1.1% from $314M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bender Robert & Associates's Q1 2021 filing shows 10 new, 22 increased, 13 reduced and 1 closed positions. Its largest new stake was Vertex Pharmaceuticals: 30,145 shares worth $6.48M. The largest sale was Vipshop, an estimated $6.81M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q1 2021 buy was Vertex Pharmaceuticals: 30,145 shares worth $6.48M.
  • Bender Robert & Associates added most to NVIDIA in Q1 2021, an estimated $622K increase.
  • Bender Robert & Associates's biggest Q1 2021 reduction was VMware, Inc, cutting an estimated $394K.
  • Bender Robert & Associates fully exited Vipshop in Q1 2021, selling an estimated $6.81M.
  • Bender Robert & Associates's ten largest holdings make up 68% of its $311M portfolio in Q1 2021.
  • Bender Robert & Associates opened 10 new positions and closed 1 in Q1 2021.
  • Bender Robert & Associates's portfolio value fell 1.1% quarter-over-quarter to $311M.

Based on Bender Robert & Associates's 13F filing for Q1 2021, filed 28 Apr 2021.